_id
6919edc03c536f8df2318486
Ticker
SAR.LSE
Name
Sareum Hldgs Plc
Exchange
LSE
Address
Langford Arch, Cambridge, United Kingdom, CB22 3FX
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.sareum.com
Description
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also develops SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Chk 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company has strategic collaboration with Receptor.AI launched in August 2025 to accelerate discovery and optimisation of BBB-permeable TYK2/JAK1 inhibitors; and completion of initial stage expected Q4 2025. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.
Last Close
150000
Volume
53992
Current Price
20
Change
0
Last Updated
2025-12-30T11:29:22.905Z
Image
https://logo.clearbit.com/www.sareum.com
Ipo Date
2004-10-11T00:00:00.000Z
Market Cap
20709776
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2036000
Operating Income
-2036000
Interest Expense
-
Pretax Income
-3575000
Net Income
-3277000
Eps
-0.024380283075099613
Dividends Per Share
-
Shares Outstanding
138065173
Income Tax Expense
-298000
EBITDA
-3579000
Operating Margin
-
Total Other Income Expense Net
-1539000
Cash
3546000
Short Term Investments
-
Receivables
684000
Inventories
-
Total Current Assets
4230000
Property Plant Equipment
0
Total Assets
4230000
Payables
198000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1953000
Equity
2277000
Bs_currency_symbol
GBP
Depreciation
-
Change In Working Capital
-10000
Cash From Operations
-1738000
Capital Expenditures
0
Cash From Investing
12000
Cash From Financing
1127000
Net Change In Cash
-598999
Cf_currency_symbol
-
PE
-
PB
1180.6051207729467
ROE
-143.91743522178305
ROA
-77.47044917257682
FCF
-1738000
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2036000
Quarters > 0 > income Statement > operating Income
-2036000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3575000
Quarters > 0 > income Statement > net Income
-3277000
Quarters > 0 > income Statement > eps
-0.024380283075099613
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
134411893
Quarters > 0 > income Statement > income Tax Expense
-298000
Quarters > 0 > income Statement > EBITDA
-3579000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1539000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3546000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
684000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4230000
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
4230000
Quarters > 0 > balance Sheet > payables
198000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1953000
Quarters > 0 > balance Sheet > equity
2277000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-3277000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-10000
Quarters > 0 > cash Flow > cash From Operations
-1738000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
12000
Quarters > 0 > cash Flow > cash From Financing
1127000
Quarters > 0 > cash Flow > net Change In Cash
-598999
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.024380283075099613
Quarters > 0 > ratios > PB
1180.6051207729467
Quarters > 0 > ratios > ROE
-143.91743522178305
Quarters > 0 > ratios > ROA
-77.47044917257682
Quarters > 0 > ratios > FCF
-1738000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1346000
Quarters > 1 > income Statement > operating Income
-1346000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1326000
Quarters > 1 > income Statement > net Income
-1161000
Quarters > 1 > income Statement > eps
-0.014334648935557864
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
80992566
Quarters > 1 > income Statement > income Tax Expense
-167000
Quarters > 1 > income Statement > EBITDA
-1326000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
18000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
4145000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
553000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
4698000
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
4705000
Quarters > 1 > balance Sheet > payables
375000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
375000
Quarters > 1 > balance Sheet > equity
4330000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-1161000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-394000
Quarters > 1 > cash Flow > cash From Operations
-736000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
3422000
Quarters > 1 > cash Flow > net Change In Cash
2685999
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.014334648935557864
Quarters > 1 > ratios > PB
374.0996120092379
Quarters > 1 > ratios > ROE
-26.812933025404156
Quarters > 1 > ratios > ROA
-24.675876726886294
Quarters > 1 > ratios > FCF
-736000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2060000
Quarters > 2 > income Statement > operating Income
-2060000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1264000
Quarters > 2 > income Statement > net Income
-911000
Quarters > 2 > income Statement > eps
-0.011247945891725421
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
80992566
Quarters > 2 > income Statement > income Tax Expense
-417000
Quarters > 2 > income Statement > EBITDA
-2025000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
732000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1459000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
78000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2758000
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
2767000
Quarters > 2 > balance Sheet > payables
542000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
653000
Quarters > 2 > balance Sheet > equity
2114000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-911000
Quarters > 2 > cash Flow > depreciation
35000
Quarters > 2 > cash Flow > change In Working Capital
355000
Quarters > 2 > cash Flow > cash From Operations
-1219000
Quarters > 2 > cash Flow > capital Expenditures
1219000
Quarters > 2 > cash Flow > cash From Investing
-28000
Quarters > 2 > cash Flow > cash From Financing
2298000
Quarters > 2 > cash Flow > net Change In Cash
1051000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.011247945891725421
Quarters > 2 > ratios > PB
766.2494418164617
Quarters > 2 > ratios > ROE
-43.09366130558184
Quarters > 2 > ratios > ROA
-32.92374412721359
Quarters > 2 > ratios > FCF
-2438000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
1000
Quarters > 3 > income Statement > gross Profit
-1000
Quarters > 3 > income Statement > operating Expenses
2535000
Quarters > 3 > income Statement > operating Income
-2536000
Quarters > 3 > income Statement > interest Expense
761000
Quarters > 3 > income Statement > pretax Income
-3278000
Quarters > 3 > income Statement > net Income
-2509000
Quarters > 3 > income Statement > eps
-0.03572986450890754
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70221369
Quarters > 3 > income Statement > income Tax Expense
-765000
Quarters > 3 > income Statement > EBITDA
-2516000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
23000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
408000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1513000
Quarters > 3 > balance Sheet > inventories
-1513000
Quarters > 3 > balance Sheet > total Current Assets
1921000
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
1967000
Quarters > 3 > balance Sheet > payables
489000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1550000
Quarters > 3 > balance Sheet > equity
417000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-2509000
Quarters > 3 > cash Flow > depreciation
1000
Quarters > 3 > cash Flow > change In Working Capital
-226000
Quarters > 3 > cash Flow > cash From Operations
-2668000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
5000
Quarters > 3 > cash Flow > cash From Financing
2077000
Quarters > 3 > cash Flow > net Change In Cash
-586000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.03572986450890754
Quarters > 3 > ratios > PB
3367.931366906475
Quarters > 3 > ratios > ROE
-601.6786570743405
Quarters > 3 > ratios > ROA
-127.55465175394
Quarters > 3 > ratios > FCF
-2668000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
3380000
Annuals > 0 > income Statement > operating Income
-3380000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-4903000
Annuals > 0 > income Statement > net Income
-4438000
Annuals > 0 > income Statement > eps
-0.035935222672064775
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
123500000
Annuals > 0 > income Statement > income Tax Expense
-465000
Annuals > 0 > income Statement > EBITDA
-3382000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1523000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
3546000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
684000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4230000
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
4230000
Annuals > 0 > balance Sheet > payables
198000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1953000
Annuals > 0 > balance Sheet > equity
2277000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-4903000
Annuals > 0 > cash Flow > depreciation
0
Annuals > 0 > cash Flow > change In Working Capital
-404000
Annuals > 0 > cash Flow > cash From Operations
-2551000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
89000
Annuals > 0 > cash Flow > cash From Financing
4549000
Annuals > 0 > cash Flow > net Change In Cash
2087000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.035935222672064775
Annuals > 0 > ratios > PB
859.6728151075978
Annuals > 0 > ratios > ROE
-194.90557751427318
Annuals > 0 > ratios > ROA
-104.91725768321514
Annuals > 0 > ratios > FCF
-2551000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1000
Annuals > 1 > income Statement > gross Profit
-1000
Annuals > 1 > income Statement > operating Expenses
4632000
Annuals > 1 > income Statement > operating Income
-4633000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-4542000
Annuals > 1 > income Statement > net Income
-3420000
Annuals > 1 > income Statement > eps
-0.04222609763962781
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
80992566
Annuals > 1 > income Statement > income Tax Expense
-1182000
Annuals > 1 > income Statement > EBITDA
-4541000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
31000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1459000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
78000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2758000
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
2767000
Annuals > 1 > balance Sheet > payables
542000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
653000
Annuals > 1 > balance Sheet > equity
2114000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-3420000
Annuals > 1 > cash Flow > depreciation
1000
Annuals > 1 > cash Flow > change In Working Capital
-171000
Annuals > 1 > cash Flow > cash From Operations
-3919000
Annuals > 1 > cash Flow > capital Expenditures
3887000
Annuals > 1 > cash Flow > cash From Investing
9000
Annuals > 1 > cash Flow > cash From Financing
4375000
Annuals > 1 > cash Flow > net Change In Cash
465000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.04222609763962781
Annuals > 1 > ratios > PB
607.2526826395459
Annuals > 1 > ratios > ROE
-161.77861873226112
Annuals > 1 > ratios > ROA
-123.59956631731117
Annuals > 1 > ratios > FCF
-7806000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1000
Annuals > 2 > income Statement > gross Profit
-1000
Annuals > 2 > income Statement > operating Expenses
4023000
Annuals > 2 > income Statement > operating Income
-4024000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-4007000
Annuals > 2 > income Statement > net Income
-3192000
Annuals > 2 > income Statement > eps
-0.046893306679757614
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
68069416
Annuals > 2 > income Statement > income Tax Expense
-833000
Annuals > 2 > income Statement > EBITDA
-4006000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-999
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
994000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
979000
Annuals > 2 > balance Sheet > inventories
-979000
Annuals > 2 > balance Sheet > total Current Assets
1973000
Annuals > 2 > balance Sheet > property Plant Equipment
1000
Annuals > 2 > balance Sheet > total Assets
2020000
Annuals > 2 > balance Sheet > payables
694000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
867000
Annuals > 2 > balance Sheet > equity
1153000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-4024000
Annuals > 2 > cash Flow > depreciation
1000
Annuals > 2 > cash Flow > change In Working Capital
346000
Annuals > 2 > cash Flow > cash From Operations
-3267000
Annuals > 2 > cash Flow > capital Expenditures
3000
Annuals > 2 > cash Flow > cash From Investing
-41000
Annuals > 2 > cash Flow > cash From Financing
3708000
Annuals > 2 > cash Flow > net Change In Cash
-3267000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.046893306679757614
Annuals > 2 > ratios > PB
935.7330820468343
Annuals > 2 > ratios > ROE
-276.84301821335646
Annuals > 2 > ratios > ROA
-158.01980198019803
Annuals > 2 > ratios > FCF
-3270000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
2000
Annuals > 3 > income Statement > gross Profit
-2000
Annuals > 3 > income Statement > operating Expenses
2577000
Annuals > 3 > income Statement > operating Income
-2580000
Annuals > 3 > income Statement > interest Expense
1000
Annuals > 3 > income Statement > pretax Income
-2579000
Annuals > 3 > income Statement > net Income
-2172000
Annuals > 3 > income Statement > eps
-0.03209251675648262
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
67679329
Annuals > 3 > income Statement > income Tax Expense
-407000
Annuals > 3 > income Statement > EBITDA
-2574000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
4261000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
500000
Annuals > 3 > balance Sheet > inventories
-500000
Annuals > 3 > balance Sheet > total Current Assets
4761000
Annuals > 3 > balance Sheet > property Plant Equipment
2000
Annuals > 3 > balance Sheet > total Assets
4786000
Annuals > 3 > balance Sheet > payables
387000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
455000
Annuals > 3 > balance Sheet > equity
4331000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-2580000
Annuals > 3 > cash Flow > depreciation
2000
Annuals > 3 > cash Flow > change In Working Capital
227000
Annuals > 3 > cash Flow > cash From Operations
-2131000
Annuals > 3 > cash Flow > capital Expenditures
3000
Annuals > 3 > cash Flow > cash From Investing
-2000
Annuals > 3 > cash Flow > cash From Financing
3708000
Annuals > 3 > cash Flow > net Change In Cash
1575000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.03209251675648262
Annuals > 3 > ratios > PB
247.68352912722236
Annuals > 3 > ratios > ROE
-50.15008081274532
Annuals > 3 > ratios > ROA
-45.38236523192645
Annuals > 3 > ratios > FCF
-2134000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.024380283075099613
Valuation > metrics > PB
1180.6051207729467
Valuation > final Score
20
Valuation > verdict
39253.5% Overvalued
Profitability > metrics > ROE
-143.91743522178305
Profitability > metrics > ROA
-77.47044917257682
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.857707509881423
Risk > metrics > Interest Coverage
-509
Risk > final Score
-1988
Risk > verdict
High
Liquidity > metrics > Current Ratio
21.363636363636363
Liquidity > metrics > Quick Ratio
21.363636363636363
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
80
Prev Risks > 1
49
Prev Risks > 2
-7
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:44.356Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-23
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
-2.41
Earnings History > 1 > eps Difference
2.4
Earnings History > 1 > surprise Percent
99.5851
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-25
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.01
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-10-11
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-03-31
Earnings History > 4 > report Date
2023-05-31
Earnings History > 4 > date
2023-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-12-31
Earnings History > 5 > report Date
2023-03-22
Earnings History > 5 > date
2022-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.02
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.02
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-09-30
Earnings History > 6 > report Date
2022-10-24
Earnings History > 6 > date
2022-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.02
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-03-31
Earnings History > 7 > report Date
2022-06-01
Earnings History > 7 > date
2022-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-12-31
Earnings History > 8 > report Date
2022-02-21
Earnings History > 8 > date
2021-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.015
Earnings History > 8 > eps Estimate
-0.02
Earnings History > 8 > eps Difference
0.005
Earnings History > 8 > surprise Percent
25
Earnings History > 9 > period
2021-09-30
Earnings History > 9 > report Date
2021-11-02
Earnings History > 9 > date
2021-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-12-31
Earnings History > 10 > report Date
2021-03-22
Earnings History > 10 > date
2020-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-09-30
Earnings History > 11 > report Date
2020-10-13
Earnings History > 11 > date
2020-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-12-31
Earnings History > 12 > report Date
2020-03-26
Earnings History > 12 > date
2019-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-09-30
Earnings History > 13 > report Date
2019-10-15
Earnings History > 13 > date
2019-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2019-06-30
Earnings History > 14 > report Date
2019-08-07
Earnings History > 14 > date
2019-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-09-30
Earnings History > 15 > report Date
2018-10-17
Earnings History > 15 > date
2018-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-12-31
Earnings History > 16 > report Date
2018-02-19
Earnings History > 16 > date
2017-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-09-30
Earnings History > 17 > report Date
2017-10-31
Earnings History > 17 > date
2017-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-02-22
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-11-21
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2015-12-31
Earnings History > 20 > report Date
2016-02-24
Earnings History > 20 > date
2015-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2013-12-31
Earnings History > 21 > report Date
2014-02-17
Earnings History > 21 > date
2013-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2013-09-30
Earnings History > 22 > report Date
2013-10-15
Earnings History > 22 > date
2013-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
GBP
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also develops SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Chk 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company has strategic collaboration with Receptor.AI launched in August 2025 to accelerate discovery and optimisation of BBB-permeable TYK2/JAK1 inhibitors; and completion of initial stage expected Q4 2025. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhat’s Next for LON SAR Share Price? Examining Today’s Trends, History, and Future Outlook Kalkine Media
Read more →PIF anchors newly-introduced Saudi bond ETF with SAR 750M ارقام
Read more →Showing 2 of 6
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Sareum Hldgs Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.01
EPS Estimate
-2.41
EPS Difference
2.4
Surprise Percent
99.5851%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.